Table 2 Univariate and multivariate logistic regression analysis of predictors for the presence of stable CAD.

From: Cardiac myosin-binding protein-C levels are associated with severity and prognosis in stable coronary artery disease

 

Unadjusted OR

95% CI

P-value

Adjusted OR

95% CI

P-value

Age (years)

1.03

1.01–1.05

0.002

1.05

1.02–1.08

0.002

Male (%)

0.38

0.24–0.58

 < 0.001

0.39

0.21–0.71

0.002

BMI (kg/m2)

0.96

0.88–1.04

0.303

   

Smoking (%)

1.78

1.11–2.90

0.018

1.36

0.71–2.63

0.354

Hypertension (%)

1.67

1.04–2.68

0.033

1.07

0.56–2.07

0.838

Diabetes (%)

2.26

1.40–3.68

 < 0.001

1.97

1.04–3.73

0.038

Family history of CVD (%)

5.08

1.11–23.26

0.036

3.35

0.61–18.32

0.163

Hemoglobin (g/L)

1.00

0.99–1.01

0.824

   

Platelets (109/L)

1.00

0.99–1.00

0.143

   

D-dimer (mg/L)

1.82

1.11–3.43

0.04

1.06

0.54–2.10

0.867

UA (μmol/L)

1.00

1.00–1.02

0.071

   

eGFR

0.99

0.98–1.00

0.019

1.00

0.99–1.02

0.744

TC (mmol/L)

0.83

0.68–1.01

0.065

   

TG (mmol/L)

0.83

0.66–1.03

0.1

   

HDL-C (mmol/L)

0.83

0.44–1.56

0.562

   

LDL-C (mmol/L)

0.84

0.67–1.05

0.13

   

LVEF (%)

0.91

0.87–0.95

 < 0.001

0.94

0.89–0.99

0.012

cMyBP-C (pg/ml)

1.07

1.05–1.08

 < 0.001

1.06

1.05–1.08

 < 0.001

cTnI (pg/ml)

4.82

0.71–32.79

0.108

   
  1. BMI, body mass index; CAD, coronary artery disease; CI, confidence interval; cMyBP-C, cardiac myosin-binding protein-C; cTnI, cardiac troponin I; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LVEF, left ventricular ejection fraction; OR, odds ratio; TC, total cholesterol; TG, triglycerides; UA, uric acid.